Aarey Drugs Board Approves 36th AGM Notice, Sets E-voting Cut-off Date
Aarey Drugs & Pharmaceuticals Limited's Board approved the notice for its 36th AGM, scheduled for September 30, 2026, via VC/OAVM. The Board also approved the Annual Report and set a cut-off date for e-voting, appointing Virendra G. Bhatt as scrutinizer.
The announcement pertains to standard corporate compliance and meeting procedures. It does not involve any significant financial transactions, strategic shifts, or operational changes that would materially impact the company's business or stock.
The announcement details routine corporate governance procedures, including the scheduling of an AGM and the approval of related reports. There are no significant financial or strategic developments mentioned.
Aarey Drugs & Pharmaceuticals Limited announced that its Board of Directors met on September 5, 2026, to consider and approve key matters related to the company's upcoming Annual General Meeting (AGM).
The Board approved the Draft Board Report, its Annexure, and the Annual Report, along with the notice for the 36th AGM, which pertains to the Financial Year ending March 31, 2026.
The 36th AGM is scheduled to be held on Wednesday, September 30, 2026, at 3:00 P.M. IST, through Video Conferencing / Other Audio Visual Means (VC/ OAVM). Additionally, the Board has approved the Book Closure of the Register of Members and Transfer Books, setting a cut-off date for e-voting purposes for the 36th AGM.
Furthermore, the Board approved the appointment of Mr. Virendra G. Bhatt, Practicing Company Secretaries (COP No. 124), as the scrutinizer for the e-voting process during the 36th AGM. The board meeting commenced at 06:00 P.M. and concluded at 7:30 P.M.
A plain-language summary of a public exchange filing by Aarey Drugs & Pharmaceuticals Limited. Read the original for the full detail.
